| P50 | author | Christophe Caux | Q56528905 |
| | Christine Ménétrier-Caux | Q71006396 |
| P2093 | author name string | Anthony Di Roio | |
| | Marion Bossennec | |
| P2860 | cites work | P-glycoprotein functions as a differentiation switch in antigen presenting cell maturation | Q79327750 |
| | The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients | Q79781706 |
| | Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis | Q80693015 |
| | Expression of the MDR1 and MRP genes in patients with lymphoma with primary bone marrow involvement | Q81048531 |
| | Expression of multidrug resistance-1 protein correlates with disease activity rather than the refractoriness to methotrexate therapy in rheumatoid arthritis | Q83174787 |
| | Autocrine Adenosine Regulates Tumor Polyfunctional CD73+CD4+ Effector T Cells Devoid of Immune Checkpoints | Q88112395 |
| | Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases | Q24601963 |
| | Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding | Q24657908 |
| | Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y? | Q27006654 |
| | Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells | Q28275578 |
| | Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor | Q28344451 |
| | Chronic inflammation up-regulates P-gp in peripheral mononuclear blood cells via the STAT3/Nf-κb pathway in 2,4,6-trinitrobenzene sulfonic acid-induced colitis mice | Q28608251 |
| | Role of P-glycoprotein in human natural killer-like cell line-mediated cytotoxicity | Q30822542 |
| | Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) | Q33194199 |
| | Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells | Q33205916 |
| | Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML). | Q33319637 |
| | Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities | Q33495468 |
| | Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody | Q33611565 |
| | Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995) | Q33758413 |
| | The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane | Q34074379 |
| | ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells | Q34463998 |
| | MDR1 polymorphisms are associated with inflammatory bowel disease in a cohort of Croatian IBD patients | Q34640725 |
| | Mammalian ABC transporters in health and disease | Q34667449 |
| | Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein) | Q34994901 |
| | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. | Q35048738 |
| | Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia | Q35377371 |
| | Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics. | Q35538527 |
| | Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance | Q35542125 |
| | Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy | Q35915497 |
| | Alterations in P-Glycoprotein Expression and Function Between Macrophage Subsets | Q36081148 |
| | Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. | Q36386127 |
| | Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients | Q36536034 |
| | Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay. | Q36821232 |
| | Characterization of the human MDR1 gene | Q37361988 |
| | Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. | Q37483138 |
| | Polymorphisms in the multidrug-resistance 1 gene related to glucocorticoid response in rheumatoid arthritis treatment. | Q37709960 |
| | P-glycoprotein Inhibition for Optimal Drug Delivery. | Q38136183 |
| | Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis | Q50449094 |
| | Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus. | Q50930116 |
| | Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. | Q51030308 |
| | Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone. | Q51031015 |
| | Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma. | Q53800155 |
| | Differential expression of the efflux pumps P-glycoprotein and multidrug resistance-associated protein in human monocyte-derived dendritic cells. | Q53991268 |
| | No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer. | Q54136949 |
| | Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques. | Q54216273 |
| | Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site | Q54242483 |
| | P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death | Q57272499 |
| | Prediction of response to disease modifying antirheumatic drugs in rheumatoid arthritis | Q59399994 |
| | Interferon-gamma up-regulates expression and activity of P-glycoprotein in human peripheral blood monocyte-derived macrophages | Q59491332 |
| | Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia | Q72229025 |
| | Altered development of intestinal intraepithelial lymphocytes in P-glycoprotein-deficient mice | Q74037893 |
| | Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. | Q38288114 |
| | P-glycoprotein (encoded by multidrug resistance genes) is not required for interleukin-2 secretion in mice and humans | Q38303929 |
| | Fragmented hyaluronan induces transcriptional up-regulation of the multidrug resistance-1 gene in CD4+ T cells | Q38308601 |
| | Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes | Q38333745 |
| | CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut. | Q38980123 |
| | Expression of multidrug resistance 1 gene in B-cell lymphomas: association with follicular dendritic cells | Q39206827 |
| | A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML. | Q39207628 |
| | MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells. | Q39242104 |
| | Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma | Q39596590 |
| | Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma | Q39787158 |
| | Substrate-dependent effects of human ABCB1 coding polymorphisms | Q40011132 |
| | Rituximab but not other anti-CD20 antibodies reverses multidrug resistance in 2 B lymphoma cell lines, blocks the activity of P-glycoprotein (P-gp), and induces P-gp to translocate out of lipid rafts | Q40232195 |
| | Verapamil induces upregulation of P-glycoprotein expression on human monocyte derived dendritic cells | Q40306083 |
| | An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell line | Q40582263 |
| | Mitotracker green is a P-glycoprotein substrate | Q40592480 |
| | Identification of a novel human memory T-cell population with the characteristics of stem-like chemo-resistance | Q40595494 |
| | The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence | Q40767154 |
| | Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells | Q40876122 |
| | Reduction of intracellular pH by inhibitors of natural killer cell activity, nicardipine, methyl 2-(N-benzyl-N-methylamino)ethyl-2,6-dimethyl-4-(2-isopropyl-pyrazolo[1, 5-a]pyridine-3-yl)-1,4-dihydro-pyridine-3,5-dicarboxylate (AHC-52), and 4,4'-dii | Q41100685 |
| | Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. | Q41172472 |
| | P-170 glycoprotein (P-170) is involved in the impairment of natural killer cell-mediated cytotoxicity in HIV+ patients | Q41298524 |
| | Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone | Q41590183 |
| | Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype | Q41592100 |
| | Phosphorylation by protein kinase C and cyclic AMP-dependent protein kinase of synthetic peptides derived from the linker region of human P-glycoprotein | Q41874604 |
| | Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function | Q41939298 |
| | CD161-expressing human T cells. | Q42082102 |
| | Altered generation of induced regulatory T cells in the FVB.mdr1a-/- mouse model of colitis. | Q42146204 |
| | A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy | Q42169041 |
| | Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. | Q42186951 |
| | Expression levels of P-glycoprotein in peripheral blood CD8+ T lymphocytes from HIV-1-infected patients on antiretroviral therapy | Q42236859 |
| | Efficient trafficking of MDR1/P-glycoprotein to apical canalicular plasma membranes in HepG2 cells requires PKA-RIIalpha anchoring and glucosylceramide | Q42416387 |
| | Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. | Q42417394 |
| | Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein | Q42464101 |
| | Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains | Q42800313 |
| | Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody. | Q42834373 |
| | Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study | Q43806484 |
| | Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice | Q43843005 |
| | Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979. | Q44231781 |
| | Influence of MDR1 C1236T polymorphism on lopinavir plasma concentration and virological response in HIV-1-infected children | Q44247691 |
| | Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavir | Q44261692 |
| | Immunological effects of taxol and adryamicin in breast cancer patients. | Q45661616 |
| | Restoration of P-glycoprotein function is involved in the increase of natural killer activity with exogenous interleukin-15 in human immunodeficiency virus-infected individuals | Q45739708 |
| | Abnormal expression of a 170-kilodalton P-glycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4+ and CD8+ T cells from patients with human immunodeficiency virus type 1 infection | Q45766786 |
| | miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1. | Q46037039 |
| | An assessment of P-glycoprotein expression and activity in peripheral blood lymphocytes of transplant candidates | Q46420437 |
| | Oxidative Stress Promotes Doxorubicin-Induced Pgp and BCRP Expression in Colon Cancer Cells Under Hypoxic Conditions. | Q46430249 |
| | Anti-P-glycoprotein antibody-induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival | Q46846341 |
| | The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids. | Q47231170 |
| | Differential activity of P-glycoprotein in normal blood lymphocyte subsets | Q47801610 |
| | Mechanism of action of human P-glycoprotein ATPase activity. Photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites | Q47922050 |
| | MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier | Q48116760 |
| P433 | issue | 12 | |
| P304 | page(s) | e1499388 | |
| P577 | publication date | 2018-09-06 | |
| P1433 | published in | OncoImmunology | Q18026500 |
| P1476 | title | MDR1 in immunity: friend or foe? | |
| P478 | volume | 7 | |